These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8558198)

  • 41. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
    Wu W; Xue YQ; Wu YF; Pan JL; Shen J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic impact of interferon alpha-induced cytogenetic remission in chronic myelogenous leukaemia: long-term follow-up.
    Kloke O; Niederle N; Opalka B; Hawig I; Seeber S; Becher R
    Eur J Haematol; 1996; 56(1-2):78-81. PubMed ID: 8599999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha).
    Steegmann JL; Requena MJ; Casado LF; Pico M; Peñarrubia MJ; Ferro MT; Resino M; Fernandez-Rañada JM
    Am J Hematol; 1996 Nov; 53(3):169-74. PubMed ID: 8895687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.
    Wang Y; Hopwood VL; Hu P; Lennon A; Osterberger J; Glassman A
    Cancer Genet Cytogenet; 2004 Aug; 153(1):53-6. PubMed ID: 15325094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extremely long-term survival of chronic myelogenous leukemia in a male with absence of the Y chromosome.
    Wang WS; Chiou TJ; Yu IT; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):132-5. PubMed ID: 8915116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cytogenetic analysis of 600 cases with chronic myelogenous leukemia].
    Xie X; Guo Y; Xue Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Apr; 15(2):85-8. PubMed ID: 9531646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.
    Lin Y; Bruyère H; Horsman DE; Pantzar T; Barnett MJ; Hogge DE; Nevill TJ; Nantel SH; Sutherland HJ; Toze CL; Shepherd JD; Lavoie JC; Song KW; Smith CA; Forrest DL
    Cancer Genet Cytogenet; 2006 Oct; 170(1):16-23. PubMed ID: 16965950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
    Deininger MW; Cortes J; Paquette R; Park B; Hochhaus A; Baccarani M; Stone R; Fischer T; Kantarjian H; Niederwieser D; Gambacorti-Passerini C; So C; Gathmann I; Goldman JM; Smith D; Druker BJ; Guilhot F
    Cancer; 2007 Oct; 110(7):1509-19. PubMed ID: 17702093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ph+ acute myelogenous leukemia with t(7;11)(p15;p15) and clonal evolution in relapse after bone marrow transplantation.
    Miura I; Nishinari T; Hashimoto K; Nimura T; Takatsu H; Niitsu H; Hirokawa M; Kuwayama A; Nishimura S; Miura AB
    Acta Haematol; 1993; 90(3):148-50. PubMed ID: 8291375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group.
    Ohnishi K; Tomonaga M; Kamada N; Onozawa K; Kuramoto A; Dohy H; Mizoguchi H; Miyawaki S; Tsubaki K; Miura Y; Omine M; Kobayashi T; Naoe T; Ohshima T; Hirashima K; Ohtake S; Takahashi I; Morishima Y; Naito K; Asou N; Tanimoto M; Sakuma A; Ohno R
    Leuk Res; 1998 Sep; 22(9):779-86. PubMed ID: 9716008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Karyotype abnormalities and their clinical significance in a group of chronic myeloid leukemia patients treated with hematopoietic stem cell transplantation.
    Otero L; Ornellas MH; de Azevedo AM; Tavares Rde C; Pires V; Abdelhay E; Bouzas LF; Fernandez Tde S
    Sao Paulo Med J; 2007 Jul; 125(4):246-9. PubMed ID: 17992398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.
    Kim M; Lee S; Jung CK; Lim J; Cho SG; Kim DW; Kim Y; Han K; Min WS; Kim CC
    Int J Lab Hematol; 2008 Dec; 30(6):508-12. PubMed ID: 18983302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple clones with (3;21) translocation in a case of Ph-positive chronic myelogenous leukemia during relapse after allogeneic bone marrow transplantation.
    Gilliland G; Patterson EJ; Rosenthal DS; Tantravahi R
    Cancer Genet Cytogenet; 1990 Jul; 47(1):55-60. PubMed ID: 2357688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
    Kantarjian HM; Keating MJ; Talpaz M; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
    Am J Med; 1987 Sep; 83(3):445-54. PubMed ID: 3477958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.
    Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Smith TL; Talpaz M; Beran M; Cork A; Trujillo JM; Freireich EJ
    Cancer; 1986 Nov; 58(9):2023-30. PubMed ID: 3463397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytogenetics of chronic myelogenous leukaemia.
    O'Brien S; Thall PF; Siciliano MJ
    Baillieres Clin Haematol; 1997 Jun; 10(2):259-76. PubMed ID: 9376663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of log-linear model in inference on karyotypic evolution in chronic myelocytic leukemia.
    Hashimoto T; Ohtaki M; Kamada N; Yamamoto H; Munaka M
    Environ Health Perspect; 1990 Jul; 87():135-41. PubMed ID: 2269218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytogenetics in patients with chronic myelogenous leukemia treated with bone marrow transplantation.
    Calabrese G; Di Bartolomeo P; Stuppia L; Guanciali Franchi P; Parruti G; Ciancarelli M; Angrilli F; Geraci L; Palka G
    Cancer Genet Cytogenet; 1989 Aug; 41(1):49-59. PubMed ID: 2670196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Karyotype evolution of Ph positive chronic myelogenous leukemia patients relapsed in advanced phases of the disease after allogeneic bone marrow transplantation.
    Sessarego M; Frassoni F; Defferrari R; Bacigalupo A; Fugazza G; Mareni C; Bruzzone R; Dejana A; Ajmar F
    Cancer Genet Cytogenet; 1991 Nov; 57(1):69-78. PubMed ID: 1756487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.